Compare stocks

Siegfried Holding AG operates in the pharmaceuticals and healthcare industry, specializing in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company provides comprehensive contract development and manufacturing services to the pharmaceutical industry, including product development, manufacturing, and packaging. Founded in 1873, Siegfried has a long-established history and is headquartered in Zofingen, Switzerland. Its strategic positioning lies in its global manufacturing network, with facilities across Europe, North America, and Asia, which allows it to serve a diverse international client base effectively. The company's competitive strength is enhanced by its integrated service offerings and commitment to quality and innovation in pharmaceutical production.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.